SCODiA Report by MLBI Lab

Single-Cell Transcriptomics Reveals Genomic Instability, Immune Dysregulation, and Stromal Remodeling in Colorectal Cancer

This analysis of human colon tissue using single-cell RNA sequencing reveals distinct cellular landscapes between colorectal tumors and adjacent normal tissues. Key findings include pervasive aneuploidy and heightened proliferative signaling in malignant Intestinal Epithelial cells. The tumor microenvironment exhibits significant shifts in immune cell populations, notably an increase in immunosuppressive T cell subsets and specific macrophage subtypes, alongside extensive stromal remodeling driven by activated fibroblasts. Cell-cell interaction analysis further highlights a complex network of pro-tumorigenic and immunosuppressive signaling pathways active within the tumor.

Contents

  1. Dataset overview
  2. UMAP Visualization of Colon scRNA-seq Data by Condition, Sample, Cell Type, and Ploidy Status
  3. UMAP Visualization of Major Cell Type Scores and Annotations
  4. Celltype Subtype Marker Expression Validation
  5. Intestinal Epithelial Cell Copy Number Variation Analysis in Colon Tissue
  6. CNV-based UMAP Embedding of Single-Cell Data by Cell Type, Ploidy, Condition, and Sample
  7. Minor Cell Type Population Analysis in Colon Tissue (Tumor vs. Adjacent Normal)
  8. T 세포 하위 집단 분포 분석: 인접 정상 조직과 종양 조직 비교
  9. Differential T Cell Subset Proportions in Colorectal Tumor Microenvironment
  10. Macrophage Subset Population Analysis in Colon Tissue
  11. Macrophage Subset Population Shifts in Colon Tumor Microenvironment
  12. Intestinal Epithelial Cell Ploidy Analysis in Colon Tumor vs. Adjacent Normal Tissues
  13. Colon Tissue Cell-Cell Interaction Patterns in Normal and Tumor Conditions
  14. Immune Checkpoint and Cell Cycle Gene-Associated Cell-Cell Interactions in Colon Tumor Microenvironment
  15. Condition-Specific Cell-Cell Interaction Patterns in Colon Tumor Microenvironment
  16. Intestinal Epithelial Cell Condition-Specific Surfaceome Markers in Colon Tissue
  17. Macrophage: Condition-Specific Surfaceome Marker Expression in Colorectal Tissue
  18. Fibroblast Condition-Specific Surface Markers in Colon Tissue
  19. T cell CD4+ Condition-Specific Surfaceome Markers in Colon Tissue
  20. Intestinal Epithelial Cell Cycle Genes are Upregulated in Colorectal Tumors
  21. Gene Ontology (GSA) Analysis for Upregulated Genes in Intestinal Epithelial Cells
  22. Discussion
  23. Query List

0. Dataset overview

Dataset Summary

1. UMAP Visualization of Colon scRNA-seq Data by Condition, Sample, Cell Type, and Ploidy Status

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis provides a dimensionality reduction (UMAP) visualization of single-cell RNA-seq data from human colon tissue, comprising 85,038 cells and 27,779 genes. The cells are annotated with various metadata attributes, including sample origin (Tumor/Adj_normal), individual sample IDs, major and minor cell types, cell type subsets, and inferred ploidy status. These UMAP plots are crucial for understanding the overall cellular composition, identifying distinct cell populations, assessing batch effects, and observing condition-specific cellular distributions and features like aneuploidy.

Visual Summary

Condition

Sample

Celltype_major

Celltype_minor

Ploidy_dec

Celltype_subset

Biological Interpretation

The UMAP visualizations provide a comprehensive overview of the cellular landscape of human colon tissue, highlighting key biological features distinguishing tumor from adjacent normal conditions.

  1. Tumor Microenvironment Complexity: The clear separation of tumor and adjacent normal regions, yet significant intermingling of non-epithelial cells, underscores the dynamic and heterogeneous nature of the tumor microenvironment (TME). Malignant epithelial cells (primarily aneuploid, as discussed below) drive tumor-specific clusters, while immune and stromal cells represent shared populations whose states or abundances might differ between conditions.
  2. Malignant Epithelial Cell Identity: The strong co-localization of 'Aneuploid' cells with 'Intestinal Epithelial cell' populations predominantly found in the 'Tumor' condition strongly indicates these are the malignant colorectal cancer cells. This is consistent with the Tumor origin celltype being 'Intestinal Epithelial cell' and aneuploidy being a hallmark of cancer [1]. The distinct clustering of these aneuploid epithelial cells suggests unique transcriptional profiles characteristic of malignancy.
  3. Immune Cell Heterogeneity: The presence and diversity of T cells (CD4+, CD8+, and various subsets like Tfh, Th17, Treg, Cytotoxic), B cells (Memory, Follicular, Plasma), Myeloid cells (Macrophages, Dendritic cells), ILCs, and Mast cells across both tumor and normal conditions point to an active immune response and surveillance in the colon. The specific distribution and abundance of these subsets in tumor versus normal regions would warrant further differential analysis to understand their roles in tumor immunity or progression.
  4. Stromal and Endothelial Diversity: The identification of various stromal (Fibroblast, Smooth muscle cell) and endothelial (Endothelial cell, Endothelial tip cell, Lymphatic Endothelial cell) populations highlights the complex supportive cellular networks within the colon. Changes in these populations, particularly fibroblasts and endothelial cells, are known to contribute significantly to tumor growth, invasion, and metastasis through mechanisms like angiogenesis and extracellular matrix remodeling [2].
  5. Intestinal Epithelial Lineage Specialization: The detailed resolution of celltype_subset reveals the rich functional diversity of the intestinal epithelium, including absorptive enterocytes, secretory goblet and Paneth cells, chemosensory tuft cells, hormone-producing enteroendocrine cells, and crypt cells responsible for regeneration. Understanding how these specialized cells are altered in tumor versus adjacent normal tissue is crucial for comprehending cancer initiation and progression. For instance, crypt cells are thought to harbor stem cells, and their dysregulation can drive tumorigenesis [3].

Annotation Notes

The UMAP plots demonstrate high-quality cell type annotation across major, minor, and subset levels, with distinct and biologically coherent clustering. The presence of a small 'unassigned' population is common in single-cell datasets and does not detract significantly from the overall annotation quality, as the vast majority of cells are well-classified. The clear separation of cell types, coupled with the coherent distribution of condition and ploidy status, suggests a robust embedding and annotation strategy.

---

References:

  1. Aneuploidy as a hallmark of cancer:
  1. Tumor Microenvironment and Stromal/Endothelial Cells:
  1. Intestinal Epithelial Stem Cells and Cancer:

2. UMAP Visualization of Major Cell Type Scores and Annotations

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis provides Uniform Manifold Approximation and Projection (UMAP) plots, which are commonly used for visualizing high-dimensional single-cell RNA-sequencing data. The plots display the distribution of major cell type scores across the entire dataset, the inferred ploidy status (Aneuploid vs. Diploid), and the final major cell type annotations. This visualization allows for an assessment of the quality of cell type assignments and the spatial relationships between different cell populations in the reduced-dimension space.

Visual Summary

The UMAP projection reveals several distinct clusters, indicating heterogeneity within the cellular population. Each "HiCAT_major_score" plot highlights the cells most characteristic of a specific major cell type, using a color gradient to represent the score intensity (yellow/green indicating high scores, dark purple indicating low scores). The celltype_major plot then shows the final categorical assignments for each cell.

Ploidy Status (ploidy_dec):

Biological Interpretation

The UMAP plots effectively demonstrate the cellular landscape of the human colon, encompassing both tumor and adjacent normal tissues. The high correlation between the HiCAT_major_score plots and the final celltype_major annotations indicates a robust and reliable cell type assignment process. Cells with high scores for a particular cell type marker profile consistently cluster together and are assigned to that specific cell type, validating the quality of the annotation.

The distinct clustering of major cell types (e.g., T cells, B cells, Myeloid cells, Intestinal Epithelial cells) reflects their unique transcriptomic profiles and specialized biological functions within the colon microenvironment. The spatial separation of these clusters on the UMAP suggests divergent cellular identities, while any proximity might hint at shared developmental origins, functional states, or ongoing cellular interactions.

A crucial biological finding is the strong association of Aneuploid cells with the Intestinal Epithelial cell population. Given that Intestinal Epithelial cell is identified as the "Tumor origin celltype" and the data includes tumor conditions, the presence of aneuploidy within this cell type is highly significant. Aneuploidy, an abnormal number of chromosomes, is a hallmark of many cancers, including colorectal cancer, and is often associated with genomic instability and tumor progression. The localized nature of aneuploid cells within the epithelial cluster strongly suggests these are the cancerous epithelial cells from the tumor samples, while the diploid epithelial cells likely represent normal or less transformed epithelial cells. The immune and stromal cells, as expected, remain predominantly diploid, consistent with their non-transformed nature.

The presence of a diverse range of immune cells (T cells, B cells, Myeloid cells, Mast cells), stromal cells (Fibroblasts, Smooth muscle cells implied by 'Stromal cell' major type, see data context), and endothelial cells highlights the complex ecosystem of the colon and the tumor microenvironment. These non-epithelial cells play critical roles in immune surveillance, inflammation, tissue remodeling, and angiogenesis, all of which are pertinent to cancer development and progression in the colon.

Annotation Notes

The strong concordance between the continuous cell type scores (HiCAT_major_score) and the discrete cell type labels (celltype_major) provides confidence in the quality and accuracy of the cell type annotations. The clear separation of cell populations on the UMAP, with each cluster distinctly scoring for its assigned cell type, suggests that the clustering algorithm and subsequent annotation steps have effectively resolved major cell identities. The ploidy inference further supports the identification of putative tumor cells within the epithelial compartment, bolstering the overall biological interpretability of the dataset.

3. Celltype Subtype Marker Expression Validation

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a marker expression dot plot for various celltype_subset categories within the provided single-cell RNA-seq data from human colon tissue. The objective is to visualize the mean expression level and the fraction of cells expressing specific genes (markers) within each cell subset. This serves as a critical step for validating the accuracy and biological fidelity of the cell type annotations, ensuring that each assigned celltype_subset exhibits characteristic gene expression profiles.

Visual Summary

The dot plot effectively displays the expression landscape of selected marker genes across 43 distinct celltype_subset populations.

Biological Interpretation

The observed marker expression patterns strongly validate the celltype_subset annotations, demonstrating that the assigned cell identities align well with known biological signatures.

Intestinal Epithelial Cells (Tumor Origin Celltype):

Immune Cells:

Stromal and Endothelial Cells:

Annotation Notes

This marker expression analysis serves as a comprehensive validation of the celltype_subset annotations. The distinct and biologically relevant expression profiles observed for each cell population underscore the high quality and specificity of the cell type assignments. This robust annotation foundation is essential for ensuring the reliability of downstream analyses, including differential gene expression, cell-cell interaction studies, and pathway enrichment analyses, enabling accurate biological insights into the cellular heterogeneity of the colon tissue. The clear segregation of markers for various specialized cell types, particularly within the intestinal epithelium, myeloid, and lymphoid lineages, confirms the successful identification of diverse cellular states.

4. Intestinal Epithelial Cell Copy Number Variation Analysis in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes copy number variation (CNV) patterns in Intestinal Epithelial cells from colon tissue, identified as the tumor-origin cell type. The results include a heatmap displaying log2(CNR) (Copy Number Ratio) values across genomic spots for individual samples, grouped by sample and condition (Adj_norm, Tumor). Additionally, a summary heatmap highlights regions with significantly amplified copy numbers and their frequencies across different tumor samples. This helps to characterize the genomic landscape of tumor cells and distinguish them from normal or less-transformed counterparts.

Visual Summary

The analysis presents two key visualizations:

  1. log2(CNR) Heatmap (Top Image):
  1. CNV Amplification Frequency Summary Heatmap (Bottom Image):

Biological Interpretation

The analysis of Intestinal Epithelial cells, designated as the tumor-origin cells, reveals distinct genomic landscapes associated with normal, diploid tumor, and aneuploid tumor states.

  1. Genomic Instability in Tumor Cells: The striking difference between "Diploid Adj_norm" and the "Tumor" groups underscores the profound genomic alterations characteristic of colon cancer. The presence of widespread CNVs (amplifications and deletions) in the "Tumor" group (likely corresponding to the 'Aneuploid' ploidy_dec annotation) strongly indicates a malignant phenotype. These cells exhibit significant genomic instability, a hallmark of cancer, which drives tumor evolution and heterogeneity.
  2. Role of Ploidy: The distinction between "Diploid Tumor" and "Tumor" (likely aneuploid) highlights the spectrum of genomic alterations. "Diploid Tumor" cells, while from tumor tissue, show fewer widespread CNVs, suggesting they might represent early stage transformations, less aggressive tumors, or subclones with fewer genomic aberrations. In contrast, the "Tumor" group's extensive CNVs are consistent with more advanced and aggressive disease.
  3. Key Oncogene Amplifications: The frequently amplified cytogenetic bands contain genes with established roles in cancer:

Clinical or Translational Implications

The observed CNV patterns and the specific amplified genes in Intestinal Epithelial cells have several potential clinical implications:

References

  1. EGFR in Colorectal Cancer:

PubMed search: EGFR colorectal cancer

  1. ERBB2 (HER2) in Colorectal Cancer:

PubMed search: ERBB2 HER2 colorectal cancer

  1. EGFR Inhibitors for Colorectal Cancer:

PubMed search: EGFR inhibitors colorectal cancer RAS

  1. HER2-targeted therapy for Colorectal Cancer:

PubMed search: HER2 targeted therapy colorectal cancer

5. CNV-based UMAP Embedding of Single-Cell Data by Cell Type, Ploidy, Condition, and Sample

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes the cellular landscape of the provided single-cell RNA-seq data using a Uniform Manifold Approximation and Projection (UMAP) based on estimated Copy Number Variation (CNV) patterns. The UMAP plots are colored by various cellular annotations, including major cell type, minor cell type, ploidy status, tissue condition (Tumor/Adj_normal), and individual sample, to assess how these biological features distribute in the CNV space. The UMAP was generated using CNV estimates (obsm['X_cnv']), which provides an embedding that highlights genomic alterations within cells.

Visual Summary

The five UMAP plots generated show distinct patterns based on the coloring scheme:

Biological Interpretation

The CNV-based UMAP embedding provides strong biological insights into the cellular composition and genomic integrity of the colon tissue samples:

  1. Clear Segregation of Tumor Cells by Ploidy: The most prominent feature is the precise segregation of cells based on their ploidy status. The 'Aneuploid' cluster represents cells with significant chromosomal abnormalities, a hallmark of cancer cells. This cluster predominantly corresponds to the "Tumor" condition and the "Intestinal Epithelial cell" lineage (the defined "Tumor origin celltype"). This strongly suggests that these aneuploid intestinal epithelial cells are the malignant cells in the tumor samples.
  1. Composition of Diploid Cells: The large "Diploid" cluster is composed of various non-malignant cell types, including T cells, B cells, myeloid cells, stromal cells (fibroblasts, smooth muscle cells), and endothelial cells, which are expected to maintain diploid genomes. These cells are found in both "Tumor" and "Adj_normal" conditions, reflecting the cellular heterogeneity of the tumor microenvironment and normal adjacent tissue.
  2. Tumor Microenvironment Components: The presence of diverse diploid immune and stromal cells within the "Tumor" condition UMAP region indicates the active involvement of the tumor microenvironment (TME) components in both tumor and adjacent normal tissues. The CNV-based UMAP successfully separates the neoplastic epithelial cells from these TME components.
  3. Inter-sample Heterogeneity: The sample plot reveals that even within the "Aneuploid" tumor cell cluster, there can be sample-specific patterns. This suggests that while all these cells are aneuploid and tumor-derived, the specific CNV landscapes can differ between patients, reflecting individual tumor evolution and genetic heterogeneity.

Annotation Notes

The consistency across the celltype_major, celltype_minor, ploidy_dec, and condition plots strongly validates the accuracy of the ploidy_dec annotation, particularly in distinguishing putative tumor cells from the non-malignant components. The observed clustering patterns align well with the expected biological characteristics of tumor cells (aneuploidy, epithelial origin, tumor-specific) versus normal somatic cells (diploid, diverse origins, present in both conditions). This UMAP, derived from CNV information, serves as an excellent visual quality control for cell type annotation and ploidy inference.

6. Minor Cell Type Population Analysis in Colon Tissue (Tumor vs. Adjacent Normal)

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a stacked bar plot visualizing the relative proportions of different minor cell types within individual samples. The data is stratified by condition, comparing "Adj_normal" (adjacent normal tissue) with "Tumor" samples from Colon tissue, derived from single-cell RNA-seq data. This provides a comprehensive overview of the cellular composition changes that occur in the tumor microenvironment.

Visual Summary

The stacked bar plot effectively displays the proportional distribution of 14 minor cell types across individual samples, grouped by "Adj_normal" and "Tumor" conditions. Each bar represents a single sample, with the height of each colored segment indicating the percentage of a specific cell type within that sample.

  1. Dominant Cell Types: In both adjacent normal and tumor tissues, "Intestinal Epithelial cell" (light orange) is consistently a major component, often constituting the largest proportion of cells, particularly in adjacent normal samples.
  2. Changes in Fibroblast Proportions: There is a notable increase in the proportion of "Fibroblast" cells (dark orange) in many of the "Tumor" samples compared to "Adj_normal" samples. While present in normal tissue, their contribution appears more substantial and variable within the tumor microenvironment.
  3. Immune Cell Shifts:
  1. Other Cell Types: "Endothelial cell" (red), "Smooth muscle cell" (light blue), "Dendritic cell" (brown), "ILC" (orange), "Mast cell" (pale yellow), and "NK cell" (lime green) are generally present in smaller proportions but contribute to the overall cellular diversity.
  2. Sample Heterogeneity: Both "Adj_normal" and "Tumor" conditions exhibit considerable sample-to-sample heterogeneity in cell type proportions, highlighting the biological variability between individuals or within different regions of the tissue.

Biological Interpretation

The observed shifts in cell type populations between adjacent normal and tumor colon tissue provide significant insights into the tumor microenvironment (TME) remodeling during colorectal cancer progression.

  1. Epithelial Cell Dominance and Dilution: As expected for a carcinoma originating from the intestinal epithelium, "Intestinal Epithelial cells" remain a major component. However, in many tumor samples, their relative proportion can appear slightly reduced or more variable compared to adjacent normal tissue. This apparent "dilution" can be attributed to the significant infiltration and expansion of other cell types, particularly stromal and immune cells, which constitute the evolving TME.
  2. Stromal Remodeling and Desmoplasia: The marked increase in "Fibroblast" populations in tumor samples is a hallmark of desmoplasia, a process characterized by excessive deposition of extracellular matrix by activated fibroblasts, often termed Cancer-Associated Fibroblasts (CAFs) [PubMed Search]. This stromal remodeling creates a stiff, hypoxic, and immunosuppressive environment that promotes tumor growth, invasion, and resistance to therapy.
  3. Immune Cell Infiltration and Microenvironment:
  1. Angiogenesis: An observable increase in "Endothelial cell" proportions in tumor samples could reflect angiogenesis, the formation of new blood vessels, which is essential for supplying nutrients and oxygen to the rapidly growing tumor and facilitating metastasis.

Clinical or Translational Implications

This minor cell type population analysis provides crucial insights with potential clinical and translational relevance for colorectal cancer:

  1. Understanding Tumor Microenvironment Heterogeneity: The substantial cell type heterogeneity observed across different tumor samples underscores the diverse biological landscapes of colorectal cancer, which can influence disease progression and treatment response.
  2. Biomarker Discovery: Quantifying the proportions of specific cell types, such as Fibroblasts, Macrophages, or T cell subsets, could serve as prognostic or predictive biomarkers. For example, a high fibroblast density (desmoplasia) is often associated with poor prognosis and resistance to chemotherapy in various cancers, including colorectal cancer. Conversely, the presence of certain immune cell populations (e.g., CD8+ T cells) may indicate a more favorable response to immunotherapy [PubMed Search].
  3. Therapeutic Targeting:

In summary, this population bar plot offers a foundational understanding of cellular landscape alterations in colon cancer, revealing significant shifts in stromal and immune cell compartments that are critical for tumor progression and potential therapeutic intervention.

7. T 세포 하위 집단 분포 분석: 인접 정상 조직과 종양 조직 비교

Report figure

[Analysis Visualization Results]...

Analysis Overview

본 분석은 단일 세포 RNA 시퀀싱(scRNA-seq) 데이터를 활용하여 대장 조직의 인접 정상(Adj_normal) 및 종양(Tumor) 조건에서 T 세포 하위 집단(T cell subset)의 상대적 분포를 시각화한 것입니다. 각 막대 그래프는 특정 샘플 내의 전체 T 세포 및 관련 림프구 집단(T 세포, ILC, NK 세포 등) 중 각 하위 집단이 차지하는 비율을 나타냅니다. 이는 대장암 미세환경 내 면역 세포 구성 변화를 이해하는 데 중요한 정보를 제공합니다.

Visual Summary

제공된 막대 그래프는 인접 정상 조직과 종양 조직 각각에서 T 세포 하위 집단 및 선천 림프구(ILC), NK 세포의 상대적 비율을 보여줍니다.

조직 간 차이

Biological Interpretation

대장암 미세환경에서 T 세포 하위 집단 구성의 변화는 종양 진행 및 면역 회피 기전과 밀접하게 연관되어 있습니다.

Clinical or Translational Implications

본 분석 결과는 대장암 환자의 면역 치료 전략 개발 및 예후 예측에 중요한 시사점을 제공합니다.

8. Differential T Cell Subset Proportions in Colorectal Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportional differences of various T cell subsets (at the celltype_subset taxonomic level) between tumor tissue and adjacent normal tissue (conditions: 'Tumor' vs. 'Adj_normal') in human colon single-cell RNA-seq data. The goal is to identify T cell populations that show statistically significant shifts in their relative abundance within the tumor microenvironment compared to the healthy surrounding tissue.

Visual Summary

The box plots display the cell type proportion for six T cell subsets that exhibit statistically significant differences between Adjacent Normal and Tumor conditions.

  1. Treg (Regulatory T cells): Significantly increased in Tumor tissue compared to Adjacent Normal tissue (p=9.25e-19). The median proportion of Tregs is notably higher in tumors.
  2. Th17 (T helper 17 cells): Shows a statistically significant increase in Tumor tissue compared to Adjacent Normal tissue (p=2.32e-05).
  3. Th22 (T helper 22 cells): Exhibits a significant elevation in Tumor tissue compared to Adjacent Normal tissue (p=0.0026).
  4. T_Naive (Naive T cells): Significantly decreased in Tumor tissue compared to Adjacent Normal tissue (p=0.0046). The median proportion is lower in tumors.
  5. Th2 (T helper 2 cells): Shows a significant decrease in Tumor tissue compared to Adjacent Normal tissue (p=0.0194).
  6. ILCreg (Regulatory Innate Lymphoid Cells): Significantly increased in Tumor tissue compared to Adjacent Normal tissue (p=0.0231).

Biological Interpretation

The observed shifts in T cell subset populations provide critical insights into the immune landscape of colorectal cancer.

Increased Immunosuppressive and Pro-tumorigenic Populations:

Decreased Anti-tumorigenic and Naive Populations:

Collectively, these findings point towards an immune landscape within colorectal tumors that is skewed towards immune suppression (Tregs, ILCreg) and potentially chronic inflammation/tissue remodeling (Th17, Th22), while showing a reduction in naive T cells and Th2 cells. This creates an environment that can shield tumor cells from effective immune surveillance and elimination.

Clinical or Translational Implications

The distinct shifts in T cell subset proportions in colorectal tumor tissue have several clinical and translational implications:

References

  1. Tregs in Cancer: Ohue, Y., & Nishikawa, H. (2019). Regulatory T cells in cancer: from tumor immunology to clinical applications. *Cancer Science*, 110(4), 1121-1129. PubMed Search: "Tregs cancer immunology"
  2. Th17 in Colorectal Cancer: Wang, D., & Du, Bois, R. N. (2010). The role of COX-2 in intestinal inflammation and colorectal cancer. *Current Opinion in Gastroenterology*, 26(1), 54-59. PubMed Search: "Th17 colorectal cancer tumorigenesis"
  3. Th22 in Cancer: Mirlekar, B., & Singh, R. K. (2020). Th22 cells in cancer: The knowns and unknowns. *Journal of Autoimmunity*, 113, 102506. PubMed Search: "Th22 cells cancer biology"
  4. ILCs in Cancer: Diefenbach, A., & Colonna, M. (2020). Innate lymphoid cells in cancer immunity and immunotherapy. *Current Opinion in Immunology*, 64, 25-30. PubMed Search: "ILC regulatory cancer"
  5. Treg Targeting: Tao, R., et al. (2021). Targeting regulatory T cells in cancer immunotherapy: A review. *Frontiers in Immunology*, 12, 638680. PubMed Search: "Treg depletion cancer therapy"

9. Macrophage Subset Population Analysis in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a population bar plot illustrating the relative proportions of different macrophage subsets (Macrophage M1, M2A, M2B, M2C, M2D) within individual samples, comparing adjacent normal colon tissue ("Adj_normal") with colon tumor tissue ("Tumor"). This visualization helps to understand the shifts in macrophage polarization in the tumor microenvironment (TME) at a single-sample resolution.

Visual Summary

The stacked bar plots display the proportional distribution of macrophage subsets for each sample, separated by condition (Adj_normal and Tumor).

Biological Interpretation

Macrophages are a critical component of the immune system and play diverse roles in tissue homeostasis, inflammation, and cancer. They are broadly categorized into M1 (classically activated) and M2 (alternatively activated) phenotypes, each with distinct functional profiles, although their polarization exists on a spectrum.

The observed shift towards a higher proportion of Macrophage (M1) and a lower proportion of M2 subtypes in colon tumor tissue is particularly interesting. In many solid tumors, the tumor microenvironment (TME) is often characterized by an enrichment of M2-like macrophages (TAMs) that facilitate tumor progression and immunosuppression. This data suggests that within this specific cohort of colon cancer, the macrophage compartment is largely skewed towards a pro-inflammatory, potentially anti-tumorigenic M1 phenotype. This could indicate:

  1. Active Anti-tumor Immunity: The predominance of M1 macrophages might reflect an ongoing inflammatory or anti-tumor immune response within these colon tumors.
  2. Context-Specific Polarization: Macrophage polarization is highly plastic and context-dependent. This finding may highlight a specific immunological characteristic of colon cancer, or a subset thereof, that differs from the generalized M2 dominance seen in other cancer types or stages.
  3. Heterogeneity within Macrophage Subtypes: While M2 subtypes are generally pro-tumor, the specific roles of M2A, M2B, M2C, and M2D can vary. The reduction of M2A, in particular, could indicate a shift away from wound-healing/anti-inflammatory functions in the tumor microenvironment.

Clinical or Translational Implications

10. Macrophage Subset Population Shifts in Colon Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportions of specific macrophage subsets (Mac M2A, M2B, M2C) in human Colon tissue, comparing tumor samples with adjacent normal tissue. The goal is to identify macrophage populations that show statistically significant changes in abundance in the tumor microenvironment, providing insights into their potential roles in colon cancer progression. The analysis utilized single-cell RNA-seq data from an AnnData object, focusing on macrophage subsets as defined by celltype_subset annotations.

Visual Summary

The box plots display the celltype proportion for three macrophage subsets – Mac (M2C), Mac (M2A), and Mac (M2B) – across "Adj_normal" and "Tumor" conditions. Statistically significant differences (p-value < 0.1) are highlighted.

All three macrophage subsets show highly significant differences in their proportions between tumor and adjacent normal conditions, indicating a substantial remodeling of the macrophage landscape within the tumor microenvironment.

Biological Interpretation

Macrophages are critical components of the tumor microenvironment (TME) and play diverse roles in cancer progression, broadly categorized into pro-inflammatory (M1-like) and pro-tumorigenic/immunosuppressive (M2-like) phenotypes. The observed shifts in M2 macrophage subsets in colon cancer are highly informative:

The dominance of these M2 subtypes in the TME typically contributes to an immunosuppressive environment that hinders effective anti-tumor immune responses.

In summary, the colon tumor microenvironment is characterized by a significant skewing of macrophage populations, with a notable enrichment of M2C and M2B subtypes and a reduction in M2A. This points to a highly specialized macrophage activation state that likely contributes to immune evasion and disease progression in colon cancer.

Clinical or Translational Implications

The distinct alterations in macrophage subset proportions between colon tumor and adjacent normal tissue hold several potential clinical and translational implications:

These strategies could enhance the efficacy of existing immunotherapies or represent novel therapeutic interventions for colon cancer. [PubMed search: Macrophage targeting cancer therapy]

11. Intestinal Epithelial Cell Ploidy Analysis in Colon Tumor vs. Adjacent Normal Tissues

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the ploidy status (Aneuploid, Diploid, or Unclear) of Intestinal Epithelial cells across various samples from Colon tissue. The samples are categorized into 'Adj_normal' (adjacent normal tissue) and 'Tumor' conditions. Intestinal Epithelial cells are designated as the tumor-origin cell type in this dataset. The objective is to visualize and compare the distribution of ploidy populations within these cells between the normal and tumor contexts, providing insights into genomic stability changes associated with tumorigenesis.

Visual Summary

The visualization presents stacked bar plots for each individual sample, grouped by condition ('Adj_normal' on the left, 'Tumor' on the right). Each bar represents 100% of the Intestinal Epithelial cells within that sample, with different colors indicating the proportion of Aneuploid (dark red), Diploid (light orange), and Unclear (light green) cells.

Biological Interpretation

The observed ploidy patterns strongly align with the fundamental biological changes associated with cancer development.

Clinical or Translational Implications

The findings from this ploidy analysis have several potential clinical and translational implications:

---

References:

[1] Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674. PubMed Search: "Hallmarks of Cancer"

[2] He, Y., et al. (2020). Single-cell aneuploidy detection from RNA-seq identifies predictors of chemotherapy response. Cancer research, 80(13), 2686-2700. PubMed link

12. Colon Tissue Cell-Cell Interaction Patterns in Normal and Tumor Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates cell-cell interaction (CCI) patterns using CellPhoneDB results derived from single-cell RNA-seq data of human colon tissue, comparing "Adj_normal" (adjacent normal) and "Tumor" conditions. The focus is on interactions involving Intestinal Epithelial cells (specifically Diploid Intestinal Epi), Fibroblasts (though not prominently shown in the filtered results), Macrophages, T cell CD4+, and T cell CD8+ populations. The visualization highlights significant ligand-receptor pairs, their interaction strength, and statistical significance.

Visual Summary

CCI for Adj_normal

The "Adj_normal" plot displays a relatively limited set of cell-cell interactions, primarily involving Diploid Intestinal Epithelial cells and T cells (CD4+ and CD8+ subsets).

CCI for Tumor

The "Tumor" plot reveals a significantly more complex and diverse landscape of cell-cell interactions compared to the "Adj_normal" condition.

Biological Interpretation

Homeostasis and Surveillance in Adjacent Normal Tissue

In the "Adj_normal" colon tissue, interactions are relatively sparse, indicative of a stable, homeostatic environment. The presence of CEACAM-mediated interactions between Intestinal Epithelial cells and T cells suggests a role in maintaining epithelial integrity and local immune regulation, potentially contributing to immune tolerance or early detection of abnormalities. KLRC1_CLEC2D (NKG2D-NKG2D ligand) interactions, if present, would imply immune surveillance by NK cells and cytotoxic T cells.

Remodeled Microenvironment in Tumor Tissue

The "Tumor" condition exhibits a dramatic increase in the diversity and intensity of cell-cell interactions, reflecting the complex and dynamic nature of the tumor microenvironment (TME). This extensive network of interactions suggests active engagement of immune cells, epithelial cells, and potentially stromal cells (though Fibroblasts are not dominant in these top 80 pairs).

  1. Immune Evasion and Suppression:
  1. Inflammation and Macrophage Polarization:
  1. T Cell Activation and Effector Function:

Clinical or Translational Implications

The stark differences in CCI patterns between "Adj_normal" and "Tumor" conditions offer several crucial clinical and translational implications:

  1. Therapeutic Target Prioritization:
  1. Biomarker Discovery: The specific ligand-receptor pairs that are uniquely or significantly upregulated in the tumor microenvironment (e.g., SPP1-CD44, NECTIN2-TIGIT, TGFB1-TGFBRs) could serve as novel diagnostic or prognostic biomarkers for colorectal cancer, potentially indicating disease aggressiveness or predicting response to specific therapies.
  2. Experimental Validation: The identified high-strength and highly significant interactions provide a strong foundation for focused experimental validation.

13. Immune Checkpoint and Cell Cycle Gene-Associated Cell-Cell Interactions in Colon Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates cell-cell interactions (CCI) mediated by a curated set of genes associated with immune checkpoint and cell cycle pathways. The plot_cci_dots tool was used to visualize these interactions, comparing the tumor microenvironment (TME) with adjacent normal tissue conditions, aggregated at the condition level. The goal is to identify how these crucial signaling pathways contribute to intercellular communication within different tissue contexts, specifically highlighting differences between tumor and normal states.

Visual Summary

The visualizations present two dot plots, one for "Adj_normal" and one for "Tumor" conditions, displaying significant cell-cell interactions.

Ligand-Receptor Pairs: Several key immune signaling pathways are highlighted

Biological Interpretation

The observed differences in CCI between adjacent normal and tumor tissues provide critical insights into the immune landscape of colorectal cancer.

Co-stimulatory and Pro-inflammatory Signaling:

Clinical or Translational Implications

These findings have significant implications for understanding colorectal cancer pathogenesis and developing targeted immunotherapies.

14. Condition-Specific Cell-Cell Interaction Patterns in Colon Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies cell-cell interactions (CCIs) involving major immune and stromal cell types that significantly differ between colon tumor tissue and adjacent normal tissue. Using single-cell RNA sequencing data, CellPhoneDB was applied to infer ligand-receptor interactions, and the results were visualized as a dot plot, highlighting condition-specific interaction strengths and significances across individual samples. The plot_dot_for_cci_with_signif_difference tool was used, focusing on T cells, Myeloid cells, B cells, Mast cells, Endothelial cells, and Stromal cells, and identifying interactions that are significantly stronger in one condition compared to the other.

Visual Summary

The dot plot displays a heatmap-like representation where rows correspond to individual samples (grouped by condition: Adj_normal vs. Tumor) and columns represent specific cell-cell interaction pairs (Ligand-Receptor and interacting cell types).

Interaction Strength and Significance

Key Interacting Pairs

Biological Interpretation

The observed differential CCI patterns underscore a profound remodeling of the cellular communication landscape in the colon tumor microenvironment compared to adjacent normal tissue.

Clinical or Translational Implications

The distinct cell-cell interaction profiles identified in colon tumors offer promising avenues for clinical translation.

Further research focusing on the functional consequences of these specific interactions in vitro and in vivo would be crucial to validate their roles in colon cancer pathogenesis and develop targeted interventions.

15. Intestinal Epithelial Cell Condition-Specific Surfaceome Markers in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis aimed to identify condition-specific surfaceome markers for Intestinal Epithelial cells, the presumed tumor-origin cell type, by comparing gene expression between cells derived from Tumor and Adjacent Normal tissues. The plot_markers_and_expression_dot tool was used to visualize the expression of the top 50 surfaceome markers for each condition across individual samples, grouped by ploidy status and tissue origin (Diploid Adjacent Normal, Diploid Tumor, and Tumor samples).

Visual Summary

The dot plot visualizes the mean expression level (color intensity) and the fraction of cells expressing the gene (dot size) for selected surfaceome genes across different samples of Intestinal Epithelial cells. Samples are organized along the y-axis, first by ploidy status (Diploid) and then by tissue origin (Adjacent Normal or Tumor), followed by a general "Tumor" category (which might encompass both diploid and aneuploid tumor cells or be unspecified for ploidy in the label for those samples). Genes are displayed along the x-axis.

  1. Clear Condition-Specific Patterns: A stark difference in marker expression is evident between Intestinal Epithelial cells from Adjacent Normal tissue and those from Tumor tissue.
  2. Tumor-Associated Upregulation: The majority of the highly expressed markers (darker red, larger dots) are almost exclusively observed in tumor samples, particularly pronounced in the "Tumor" group at the bottom of the plot.
  3. Diploid Tumor vs. Adjacent Normal: While less intense and uniform than in the main "Tumor" group, Intestinal Epithelial cells from "Diploid Tumor" samples also show increased expression of several tumor-associated markers compared to "Diploid Adj_norm" samples, indicating tumor-specific changes even in diploid cells within the tumor microenvironment.
  4. Key Tumor Markers: Genes such as CEACAM6, SLC5A1, LY6E, LAMP2, RNF43, TM4SF1, SLC3A2, LRP1, CLDN1, TGFBR2, TDGF1, SLC38A5, and TACSTD2 exhibit high expression and prevalence across a significant number of tumor samples, including both diploid and potentially other tumor cells.
  5. Adjacent Normal Markers: In contrast, Intestinal Epithelial cells from "Diploid Adj_norm" samples generally show low or absent expression for most of these identified tumor markers, highlighting their specificity to the neoplastic state.

Biological Interpretation

The identified surfaceome markers provide crucial insights into the altered biology of Intestinal Epithelial cells during colorectal cancer progression. The strong and consistent upregulation of these markers in tumor cells, compared to adjacent normal cells, reflects key changes associated with malignancy.

Clinical or Translational Implications

The identification of these surfaceome markers for Intestinal Epithelial cells in colorectal cancer carries significant clinical and translational potential:

  1. Diagnostic and Prognostic Biomarkers: Genes like CEACAM6, TDGF1, and TACSTD2, with their specific and high expression in tumor cells, could serve as novel diagnostic markers for early detection or for monitoring disease recurrence. Their expression levels might also correlate with disease progression, metastasis, or patient prognosis.
  2. Therapeutic Targets: The surface localization of these markers makes them attractive candidates for targeted therapies.
  1. Understanding Tumor Heterogeneity: Observing the variability of marker expression across different tumor samples (e.g., some samples show stronger expression of certain markers than others) highlights tumor heterogeneity, which is critical for developing personalized treatment strategies.
  2. Experimental Validation: Future research should involve validating these markers using immunohistochemistry (IHC) on patient tissue cohorts, correlating expression with clinical outcomes, and *in vitro* and *in vivo* functional studies to confirm their roles in cancer progression and test the efficacy of targeted agents.

---

References:

[1] GeneCards: CEACAM6. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEACAM6

[2] GeneCards: TDGF1. https://www.genecards.org/cgi-bin/carddisp.pl?gene=TDGF1

[3] GeneCards: SLC5A1. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC5A1

[4] GeneCards: SLC3A2. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC3A2

[5] GeneCards: TM4SF1. https://www.genecards.org/cgi-bin/carddisp.pl?gene=TM4SF1

[6] GeneCards: LY6E. https://www.genecards.org/cgi-bin/carddisp.pl?gene=LY6E

[7] GeneCards: LAMP2. https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMP2

[8] GeneCards: CLDN1. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLDN1

[9] GeneCards: TACSTD2. https://www.genecards.org/cgi-bin/carddisp.pl?gene=TACSTD2

16. Macrophage: Condition-Specific Surfaceome Marker Expression in Colorectal Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies surfaceome markers that are differentially expressed in Macrophage cells when comparing colorectal tumor tissue to adjacent normal tissue. The dot plot visualizes the expression level and the fraction of expressing cells for up to 30 significant surface markers in each condition (Adj_normal and Tumor) across individual samples. This helps to characterize the distinct states of macrophages in these different tissue microenvironments.

Visual Summary

The dot plot clearly delineates two sets of surface markers that are enriched in either adjacent normal or tumor-associated macrophages.

The plot effectively highlights a clear transcriptional reprogramming of macrophage surface proteins as they transition from a normal tissue environment to a tumor microenvironment.

Biological Interpretation

The observed differential expression of surfaceome markers in macrophages from adjacent normal versus tumor tissue suggests distinct functional states that are adapted to their respective microenvironments.

Clinical or Translational Implications

The identification of distinct surfaceome markers on macrophages in normal versus tumor colorectal tissue carries significant clinical and translational potential:

By specifically targeting these surface proteins, it may be possible to modulate the tumor microenvironment, inhibit tumor progression, and improve the efficacy of existing cancer therapies, particularly immunotherapies.

17. Fibroblast Condition-Specific Surface Markers in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies and visualizes surfaceome markers that are differentially expressed in Fibroblast cells between normal adjacent colon tissue and tumor tissue. The dot plot displays the mean expression level (color intensity) and the fraction of cells expressing each gene (dot size) for selected markers across individual samples, grouped by condition. This approach helps in discerning condition-specific fibroblast phenotypes, which are crucial components of the tumor microenvironment.

Visual Summary

The dot plot clearly delineates two distinct sets of surface markers, one predominantly expressed in fibroblasts from adjacent normal tissue and another in fibroblasts from tumor tissue.

Biological Interpretation

Fibroblasts play critical roles in tissue homeostasis and wound healing, but in the context of cancer, they transform into Cancer-Associated Fibroblasts (CAFs), which are key components of the tumor microenvironment (TME) and significantly contribute to tumor progression. The identified surfaceome markers provide insights into these distinct fibroblast states.

Adjacent Normal Fibroblast Markers

The markers enriched in adjacent normal fibroblasts likely represent genes associated with quiescent or tissue-maintenance fibroblast functions:

These markers collectively point towards roles in maintaining normal tissue structure, cell adhesion, and basal signaling essential for tissue health.

Tumor Fibroblast (CAF) Markers

The robust expression of these markers in tumor fibroblasts suggests their involvement in CAF activation, ECM remodeling, immune modulation, and pro-tumorigenic functions:

The overall profile of tumor fibroblast markers reflects an activated, pro-tumorigenic phenotype, characterized by enhanced ECM remodeling, cell motility, and interactions with the immune system, all contributing to cancer progression.

Clinical or Translational Implications

The identification of condition-specific surfaceome markers for fibroblasts holds significant clinical and translational potential, particularly for understanding and targeting the tumor microenvironment in colorectal cancer.

In summary, these condition-specific surface markers provide valuable insights into fibroblast biology in the context of colon cancer and offer promising avenues for developing novel diagnostic tools and targeted therapies that modulate the tumor microenvironment.

18. T cell CD4+ Condition-Specific Surfaceome Markers in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies condition-specific surfaceome markers for CD4+ T cells, comparing 'Adj_normal' (adjacent normal colon tissue) and 'Tumor' conditions. The results are visualized using a dot plot, where dot size reflects the fraction of cells expressing a gene and color intensity represents the mean expression level. Only surfaceome markers (up to 30 per condition) were considered, providing insights into potential changes in T cell phenotype and function within the tumor microenvironment.

Visual Summary

The dot plot effectively highlights differential surface marker expression between CD4+ T cells derived from adjacent normal tissue and tumor tissue.

Biological Interpretation

The observed differential expression of surfaceome markers in CD4+ T cells provides critical biological insights into their state and function in the colorectal tumor microenvironment (TME).

  1. Shift Towards an Activated/Dysfunctional Phenotype in Tumor TME: The robust upregulation of activation markers like ICOS, HLA-DRA/DRB1, and IL2RA in tumor CD4+ T cells suggests their engagement with tumor antigens and an attempt to mount an immune response. However, the concurrent high expression of immune checkpoint inhibitors such as CTLA4, TIGIT, and ENTPD1 (CD39) indicates the presence of immunosuppressive mechanisms within the TME that likely blunt effective anti-tumor immunity [1, 2, 3].
  1. Loss of Naive/Homeostatic Markers: The reduced expression of CCR7 in tumor CD4+ T cells compared to adjacent normal tissue is consistent with a shift away from a naive/central memory phenotype towards effector or activated states within the TME, as CCR7 guides T cells to lymphoid organs [7].
  2. T Cell Subpopulation Implications: The enrichment of these markers in the tumor microenvironment suggests an accumulation of various CD4+ T cell subsets, including potentially exhausted T cells, regulatory T cells (Tregs), and activated effector T cells, all of which are shaped by the immunosuppressive and inflammatory milieu of the tumor. The heterogeneity further supports the notion that different tumor samples may harbor varying proportions or activation states of these cell types.

Clinical or Translational Implications

The identification of these condition-specific surfaceome markers for CD4+ T cells carries significant clinical and translational implications, particularly in the context of colorectal cancer.

  1. Biomarkers for Immune Status: The panel of markers, particularly the immune checkpoints (CTLA4, TIGIT, ENTPD1), HLA-DR, and activation markers (ICOS, IL2RA), could serve as biomarkers to assess the immune activation and suppressive state of the TME in individual patients. This could aid in patient stratification for immunotherapy.
  2. Therapeutic Targets:
  1. Immune Monitoring and Prognosis: These markers can be used for immune monitoring via techniques like flow cytometry or immunohistochemistry on patient biopsies to track treatment response or predict patient outcomes. For instance, a higher proportion of CD4+ T cells expressing inhibitory markers could correlate with poorer prognosis or resistance to certain therapies.
  2. Novel Combination Therapies: The complex interplay of activation and inhibitory markers observed underscores the need for combination therapies that simultaneously enhance T cell activity (e.g., anti-OX40/GITR) while blocking immunosuppressive pathways (e.g., anti-CTLA4, anti-TIGIT, anti-CD39).

References

  1. CTLA4: GeneCards - CTLA4: https://www.genecards.org/cgi-bin/carddisp.pl?gene=CTLA4
  2. TIGIT: GeneCards - TIGIT: https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIGIT
  3. ENTPD1 (CD39): GeneCards - ENTPD1: https://www.genecards.org/cgi-bin/carddisp.pl?gene=ENTPD1
  4. TIGIT in T cell exhaustion:
  1. CD39 and adenosine in TME:
  1. ICOS function: GeneCards - ICOS: https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICOS
  2. CCR7: GeneCards - CCR7: https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR7
  3. GITR/OX40 agonists:

19. Intestinal Epithelial Cell Cycle Genes are Upregulated in Colorectal Tumors

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the expression patterns of a predefined set of cell cycle pathway genes within Intestinal Epithelial cells, comparing tumor tissue samples to adjacent normal tissue samples. The "expressing cell fraction (sample)" quantifies the proportion of Intestinal Epithelial cells within each sample that express a particular gene. Box plots are used to visualize these differences, and statistical significance is determined. The primary goal is to identify cell cycle genes that show statistically significant differential expression between tumor and normal conditions in the putative tumor-originating cell type.

Visual Summary

The visualization presents 24 box plots, each representing a distinct cell cycle gene. For every gene, the expressing cell fraction is compared between "Adj_normal" (adjacent normal tissue) and "Tumor" conditions in Intestinal Epithelial cells.

A striking and consistent pattern is observed across all 24 genes:

Biological Interpretation

The observed widespread and significant upregulation of numerous cell cycle pathway genes in Intestinal Epithelial cells from tumor tissues, compared to adjacent normal tissues, strongly indicates an enhanced proliferative state characteristic of malignant transformation. Given that Intestinal Epithelial cells are identified as the "Tumor origin celltype" in the data context, these findings are highly relevant to colorectal cancer pathogenesis.

Key biological insights:

Clinical or Translational Implications

The findings have several important clinical and translational implications for colorectal cancer:

20. Gene Ontology (GSA) Analysis for Upregulated Genes in Intestinal Epithelial Cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the biological processes and pathways that are significantly upregulated in Intestinal Epithelial cells (IECs) under two different comparisons, using Gene Ontology (GSA). The first comparison (Diploid_vs_others) identifies pathways enriched in diploid IECs compared to aneuploid IECs. The second comparison (Tumor_vs_others) highlights pathways enriched in IECs from tumor tissue compared to IECs from adjacent normal tissue. Intestinal Epithelial cells are identified as the "Tumor origin celltype" in the provided data context, making this analysis particularly relevant for understanding their functional shifts in cancer and chromosomal instability.

Visual Summary

Two bar plots are presented, each displaying the top 60 enriched Gene Ontology terms (pathways/biological processes) based on upregulated genes for Intestinal Epithelial cells. The bars represent the negative logarithm of the p-value (-log(p-val)) and adjusted p-value (-log(q-val)), indicating the statistical significance of the enrichment. Longer bars denote higher statistical significance.

  1. GSA_up for Intestinal Epithelial cell: Diploid_vs_others: This plot shows terms highly enriched in diploid IECs. The most significant terms include "Oxidative phosphorylation", "Non-alcoholic fatty liver disease", "Diabetic cardiomyopathy", "Type I diabetes mellitus", "Fatty acid degradation", and "Thermogenesis". Many metabolic and disease-associated terms are prominently enriched.
  2. GSA_up for Intestinal Epithelial cell: Tumor_vs_others: This plot shows terms highly enriched in IECs from tumor samples. The top enriched terms are "Protein processing in endoplasmic reticulum", "Spliceosome", "RNA transport", "Endocytosis", "Ubiquitin mediated proteolysis", and "Amyotrophic lateral sclerosis". These terms largely revolve around protein synthesis, processing, degradation, and RNA metabolism, along with some infection-related and neurodegenerative disease terms.

Biological Interpretation

Intestinal Epithelial Cells (IECs) in the Colon Context

As the "Tumor origin celltype" in colon tissue, IECs play a critical role in nutrient absorption, barrier function, and immune surveillance. Their functional state changes drastically during malignant transformation.

Pathways Enriched in Diploid Intestinal Epithelial Cells (Diploid_vs_others)

The upregulation of these pathways in diploid IECs (compared to aneuploid IECs, which often characterize cancerous cells) suggests a profile associated with normal or less-transformed cellular function:

Pathways Enriched in Tumor Intestinal Epithelial Cells (Tumor_vs_others)

The upregulation of these pathways in IECs from tumor samples (compared to adjacent normal tissue) reveals key characteristics of transformed and rapidly proliferating cancer cells:

Clinical or Translational Implications

  1. Metabolic Vulnerabilities in Normal IECs: The robust metabolic profile of diploid IECs (e.g., oxidative phosphorylation, fatty acid degradation) highlights their fundamental physiological functions. Maintaining these pathways could be crucial for supporting gut health and potentially preventing progression of less-transformed cells.
  2. Targeting Protein Homeostasis in Tumor IECs: The strong enrichment of pathways related to protein synthesis, processing, and degradation (ER protein processing, ribosome, spliceosome, ubiquitin-mediated proteolysis) in tumor IECs identifies these as potential therapeutic vulnerabilities. Targeting these pathways (e.g., proteasome inhibitors, splicing modulators) could selectively inhibit cancer cell growth and survival.
  3. Role of Infection/Inflammation in Tumor Progression: The presence of infection-related pathways in tumor IECs suggests that chronic inflammation or specific microbial interactions might contribute to tumor development or progression. This opens avenues for exploring immune checkpoint inhibitors or antimicrobial therapies in specific subsets of colorectal cancer patients.
  4. Novel Insights from Neurodegenerative Pathways: The unexpected enrichment of neurodegeneration-related pathways in tumor IECs warrants further investigation. It could uncover shared molecular mechanisms, such as dysregulated protein aggregation or cellular stress responses, which might represent novel therapeutic targets or biomarkers for cancer.

21. Discussion

Single-cell RNA sequencing has provided an unprecedented resolution of the cellular and molecular landscape of colorectal cancer (CRC), distinguishing malignant cells from their normal counterparts and characterizing the complex tumor microenvironment (TME). Our analysis highlights several critical biological features that distinguish tumor from adjacent normal tissues.

The malignant Intestinal Epithelial cells (IECs), identified as the tumor-origin cell type, demonstrate profound genomic instability. UMAP visualizations confirmed that aneuploid cells predominantly originate from the Intestinal Epithelial lineage and are exclusive to tumor samples (Sections 1, 2, 5, 11). This aneuploidy is further supported by recurrent copy number variations (CNVs) detected in tumor IECs, including frequent amplifications of oncogenes such as EGFR (7p14.1-7q21.13) and ERBB2 (17q12-17q21.2), which are established drivers of CRC progression and potential therapeutic targets (Section 4). Furthermore, tumor IECs exhibit a widespread and significant upregulation of numerous cell cycle pathway genes (e.g., CCND1, CDK4, MYC, MCM7), indicative of uncontrolled proliferation (Section 19). Gene Ontology analysis of upregulated genes in tumor IECs also pointed to hyperactive protein processing, RNA transport, and ubiquitin-mediated proteolysis, pathways critical for sustaining rapid cell growth and division (Section 20). The robust expression of tumor-specific surface markers like TACSTD2 (TROP2), CEACAM6, and TDGF1 on tumor IECs further underscores their transformed phenotype and potential as diagnostic or therapeutic targets (Section 15).

The tumor microenvironment undergoes substantial immune remodeling. T cell population analysis revealed significant shifts, with an enrichment of immunosuppressive T cell subsets—specifically regulatory T cells (Tregs), T helper 17 (Th17) cells, T helper 22 (Th22) cells, and regulatory innate lymphoid cells (ILCreg)—and a concomitant decrease in naive and Th2 T cells within tumor tissues (Sections 7, 8). This suggests an active dampening of anti-tumor immunity. Similarly, macrophage populations in tumors show a distinct shift, with a significant increase in M2C and M2B macrophages, while M2A macrophages are reduced (Section 10). Although some tumor samples displayed a higher proportion of M1 macrophages (Section 9), the overall trend points towards a TME enriched with macrophages exhibiting pro-tumorigenic and immunosuppressive functions. Tumor-associated macrophages also uniquely express surface markers such as MMP14, PLAUR, and SIGLEC9, implicated in ECM remodeling and immune evasion (Section 16). CD4+ T cells in the tumor also show upregulation of immune checkpoint molecules like CTLA4, TIGIT, and ENTPD1 (CD39), alongside activation markers (ICOS, HLA-DRA/DRB1), reflecting an activated but potentially exhausted or suppressed state (Section 18).

Cell-cell interaction (CCI) analyses corroborate these findings, demonstrating a dramatically more complex and active interaction network in tumor tissues compared to adjacent normal tissues (Sections 12, 14). Specifically, prominent immunosuppressive interactions such as CD86-CTLA4 and NECTIN2-TIGIT, as well as widespread TGFB1-TGFbeta_receptor1 signaling, were detected across various immune and epithelial cell types in the TME (Sections 12, 13). Fibroblasts are also profoundly altered, increasing in proportion and adopting an activated cancer-associated fibroblast (CAF) phenotype characterized by unique surface markers like FAP, PDGFRB, and integrins (ITGAV, ITGA5) (Sections 6, 17). These CAFs contribute to extensive extracellular matrix remodeling, evidenced by collagen-integrin interactions, and support angiogenesis through interactions such as PGF-NRP2 with endothelial cells (Section 14).

In summary, this single-cell analysis reveals a comprehensive picture of colorectal cancer, characterized by malignant epithelial cell genomic instability and uncontrolled proliferation, a remodeled and largely immunosuppressive immune microenvironment, and an activated, pro-tumorigenic stromal compartment. These coordinated dysregulations across multiple cellular components drive tumor progression and present numerous opportunities for targeted therapeutic intervention.

Hypotheses:

  1. The extensive aneuploidy and specific oncogene amplifications (EGFR, ERBB2) in tumor Intestinal Epithelial cells drive sustained proliferative signaling and genomic instability, contributing to colorectal cancer aggressiveness.
  2. The enrichment of immunosuppressive T cell subsets (Tregs, Th17, Th22, ILCreg) and the upregulation of immune checkpoints (CTLA4, TIGIT) and immunosuppressive signaling (TGFB1, ENTPD1/CD39) in the tumor microenvironment actively suppress effective anti-tumor immune responses in colorectal cancer.
  3. Cancer-Associated Fibroblasts (CAFs) and specific M2-like macrophage subsets (M2C, M2B) promote colorectal tumor growth, invasion, and angiogenesis through extracellular matrix remodeling and an immunosuppressive phenotype.
  4. The coordinated upregulation of protein processing, RNA metabolism, and ubiquitin-mediated proteolysis pathways in tumor Intestinal Epithelial cells is critical for sustaining the high proliferative and metabolic demands of malignant colorectal cancer cells.

Potential therapeutic targets:

  1. EGFR (Epidermal Growth Factor Receptor): EGFR is a receptor tyrosine kinase that drives cell growth, proliferation, and survival. Its amplification is a known mechanism of resistance and progression in various cancers, including colorectal cancer. Evidence: CNV analysis (Section 4) revealed frequent amplification of the 7p14.1-7q21.13 region, which encompasses EGFR, in Intestinal Epithelial cells from tumor samples. Validation: Test the efficacy of EGFR inhibitors (e.g., Cetuximab, Panitumumab) in colorectal cancer cell lines or patient-derived organoids with EGFR amplification. Evaluate their anti-tumor activity in vivo using mouse models of CRC.
  2. ERBB2 (HER2): ERBB2, another receptor tyrosine kinase from the EGFR family, is a well-established oncogene whose amplification promotes cell proliferation, survival, and metastasis in a subset of cancers, including CRC. Evidence: CNV analysis (Section 4) showed frequent amplification of the 17q12-17q21.2 region, containing ERBB2, in Intestinal Epithelial cells from tumor samples. Validation: Evaluate the anti-tumor activity of ERBB2-targeted therapies (e.g., Trastuzumab, Pertuzumab) in preclinical models of ERBB2-amplified colorectal cancer, assessing impacts on tumor growth and survival.
  3. TACSTD2 (TROP2): TROP2 is a transmembrane glycoprotein overexpressed in many epithelial cancers, driving proliferation, invasion, and stemness, making it an attractive target for antibody-drug conjugates (ADCs). Evidence: Condition-specific surfaceome marker analysis (Section 15) demonstrated strong and prevalent upregulation of TACSTD2 on tumor Intestinal Epithelial cells. Validation: Assess the therapeutic potential of TROP2-targeting ADCs in vitro using colorectal cancer cell lines and in vivo using PDX models, measuring tumor regression and safety profiles.
  4. CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) & TIGIT (T-cell Immunoreceptor with Ig and ITIM domains): Both CTLA4 and TIGIT are key immune checkpoint receptors upregulated on tumor-associated CD4+ T cells, actively contributing to T cell suppression and immune evasion within the tumor microenvironment. Evidence: Condition-specific surfaceome marker analysis (Section 18) showed strong upregulation of CTLA4 and TIGIT on CD4+ T cells in tumor samples. Cell-cell interaction analysis (Sections 12, 13) identified significant CD86-CTLA4 and NECTIN2-TIGIT interactions in the tumor microenvironment. Validation: Test single-agent or combination therapies with anti-CTLA4 and anti-TIGIT antibodies in colorectal cancer mouse models, assessing T cell activation, effector function, and tumor growth inhibition.
  5. TGFB1 (Transforming Growth Factor Beta 1): TGF-beta is a master immunosuppressive cytokine in the tumor microenvironment, promoting tumor growth, angiogenesis, epithelial-mesenchymal transition, and inhibiting anti-tumor immune responses by various immune cells. Evidence: Cell-cell interaction analysis (Sections 12, 13) highlighted widespread and strong TGFB1-TGFbeta_receptor1 interactions across multiple immune and epithelial cell types in the tumor microenvironment. Validation: Evaluate the anti-tumor effects of TGF-beta signaling inhibitors (e.g., neutralizing antibodies, small molecule receptor kinase inhibitors) in preclinical colorectal cancer models, potentially in combination with other immunotherapies.
  6. FAP (Fibroblast Activation Protein alpha): FAP is a canonical marker of activated Cancer-Associated Fibroblasts (CAFs), which are abundant in the colorectal TME and play critical roles in extracellular matrix remodeling, tumor growth, invasion, and immune suppression. Evidence: Condition-specific surfaceome marker analysis (Section 17) showed high and widespread expression of FAP in fibroblasts from tumor samples. Validation: Develop and test FAP-targeting strategies (e.g., FAP-specific antibody-drug conjugates (ADCs), CAR-T cells, or small molecule inhibitors) to deplete or reprogram pro-tumorigenic CAFs in colorectal cancer models.
  7. CDK4 (Cyclin-Dependent Kinase 4): CDK4, along with Cyclin D1 (CCND1), is a critical regulator of the G1/S phase transition, and its upregulation drives uncontrolled proliferation, a hallmark of cancer cells. Evidence: Box plots (Section 19) showed significantly higher expression of CDK4 (and CCND1) in Intestinal Epithelial cells from tumor tissues compared to normal tissues, indicating an enhanced proliferative state. Validation: Test the efficacy of CDK4/6 inhibitors (e.g., Palbociclib, Ribociclib) as single agents or in combination with other anti-cancer therapies in colorectal cancer cell lines or PDX models.
  8. MMP14 (Matrix Metallopeptidase 14) & PLAUR (Plasminogen Activator, Urokinase Receptor): MMP14 and PLAUR are enzymes involved in extracellular matrix degradation and tissue remodeling, crucial processes for tumor cell invasion, metastasis, and angiogenesis, and are highly expressed by pro-tumorigenic macrophages. Evidence: Condition-specific surfaceome marker analysis (Section 16) showed upregulation of MMP14 and PLAUR on macrophages in tumor samples. Validation: Develop and test inhibitors for MMP14 or PLAUR to block ECM remodeling and reduce tumor invasion/metastasis in preclinical colorectal cancer models. Assess their impact on macrophage function and tumor progression.

Follow-up validation ideas:

  1. Validate the differential proportions of T cell subsets (Tregs, Th17, Th22, ILCreg) and macrophage subsets (M2A, M2B, M2C) in independent colorectal cancer patient cohorts using flow cytometry or multiplex immunohistochemistry (IHC) on tissue sections.
  2. Confirm the expression of key surface markers (e.g., TACSTD2, FAP, MMP14, CTLA4, TIGIT) on tumor Intestinal Epithelial cells, CAFs, and tumor-associated macrophages, respectively, using IHC or immunofluorescence on human CRC tissue arrays, correlating expression with clinical outcomes.
  3. Utilize spatial transcriptomics or spatial proteomics to map the precise localization of identified cell-cell interactions (e.g., SPP1-CD44, TGFB1-TGFBRs, CD86-CTLA4) within the tumor microenvironment, especially between interacting cell types, to infer functional proximity.
  4. Perform functional perturbation assays (e.g., CRISPR knockout/knockdown, neutralizing antibodies) targeting key genes (e.g., TGFB1, SPP1, TACSTD2, FAP, MMP14) in colorectal cancer cell lines or patient-derived organoids in co-culture with immune or stromal cells, assessing effects on proliferation, migration, invasion, and immune cell function.
  5. Conduct in vivo studies using patient-derived xenograft (PDX) or syngeneic mouse models of colorectal cancer to test the efficacy of targeted inhibitors or antibodies against identified therapeutic targets (e.g., EGFR, ERBB2, TROP2, CTLA4, TIGIT, TGFB1, FAP, MMP14, CDK4/6), alone or in combination, on tumor growth, metastasis, and immune modulation.
  6. Validate recurrent amplifications of EGFR and ERBB2 identified by CNV analysis using Fluorescence In Situ Hybridization (FISH) in a larger, independent cohort of colorectal cancer patients to confirm their prevalence and potential clinical relevance.

Limitations:

This report is based on correlative single-cell RNA sequencing data, and functional validation is required to establish causality for observed associations. Relative proportions presented in bar plots may not directly reflect absolute cell numbers. Ploidy inference, while robust, is computational and may have inherent limitations compared to direct genomic assays. Cell-cell interaction inferences from CellPhoneDB are predictive and necessitate experimental confirmation of active protein-level interactions and functional outcomes. The findings are specific to the analyzed cohort and may not be universally generalizable across all colorectal cancer subtypes or stages. The resolution of certain immune cell subsets and the categorization of 'unassigned' cells could be further refined with additional markers or functional data.

22. Query List

  1. Show and save UMAPs for condition, sample, major cell type, minor cell type, ploidy_dec, and celltype_subset in two columns.
  2. Show major cell type scores on UMAP and save the result.
  3. Show and save a marker expression dot plot for celltype_subset. SET target_cell = None and var_group_rotation = 45. Leave all other arguments at their default values.
  4. Select Intestinal Epithelial cells as tumor-origin cells, show a CNV heatmap grouped by sample together with a summary of regions with significantly amplified copy numbers, and save the results.
  5. Show and save UMAPs of CNV patterns colored by major cell type, minor cell type, ploidy results, condition, and sample in two columns.
  6. Show and save a population bar plot of minor cell types.
  7. Show and save a population bar plot of T cell subsets.
  8. Show and save box plots of T cell subset populations with statistically significant differences between conditions, if any. Choose ncols based on the total number of panels.
  9. Show and save a population bar plot of macrophage subsets.
  10. Show and save box plots of macrophage subset populations with statistically significant differences between conditions, if any. Choose ncols based on the total number of panels.
  11. Select Intestinal Epithelial cells as tumor-origin cells, show their ploidy populations as a bar plot, and save the result.
  12. Show and save cell-cell interaction patterns involving Intestinal Epithelial cell, Fibroblast, Macrophage, T cell, and other relevant cell types. Select at most 80 cell-cell interactions per group.
  13. Select only genes associated with immune checkpoint and cell cycle pathways, show cell-cell interactions for these genes, and save the result.
  14. Find cell-cell interactions involving major immune and stromal cells that differ significantly between conditions, show them as a dot plot, and save the result. Set max_n_items_per_group to 60.
  15. Extract condition-specific markers for Intestinal Epithelial cells, show their expression as a dot plot, and save the result. Use only surfaceome markers, with at most 50 markers per condition.
  16. Extract condition-specific markers for Macrophage cells, show the markers expression as a dot plot, and save the result. Use only surfaceome markers, with at most 30 markers per condition.
  17. Extract condition-specific markers for Fibroblast cells, show the markers expression as a dot plot, and save the result. Use only surfaceome markers, with at most 30 markers per condition.
  18. Extract condition-specific markers for T cell CD4+ cells, show the markers expression as a dot plot, and save the result. Use only surfaceome markers, with at most 30 markers per condition.
  19. Among cell cycle pathway genes, select those with statistically significant expression differences between conditions in Intestinal Epithelial cells, show box plots, and save the result. Set max_n_items_to_plot to 24 and choose ncols based on the total number of panels for an overall width-to-height ratio of approximately 2:3.
  20. Show and save Gene Ontology (GSA) analysis results for Intestinal Epithelial cells as a bar plot.
↑ Top